FDA Investigator Robert Jennings

Robert Jennings has conducted inspections on 44 sites in 8 countries as of 22 Jan 2004. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
44
Last Inspection Date:
22 Jan 2004
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America, Denmark, Germany, United Kingdom of Great Britain and Northern Ireland, Netherlands, France, Japan, Puerto Rico
FDA Investigators that have inspected at least one site in common with Robert Jennings:
Adam R Cooke, Adetutu M Gidado, Aikaterini Alexaki, Alicia Gilbert, Allen Lou, Althea A Williams, Amber D Brodas, Amy C Jordan, Andrew C Chang, Andrew J Lang, Andrew M Barlow, Angela K Shen, Anh M Lac, Anissa M Cheung, Anita Narula, PhD, Anita R Michael, Ann L Demarco, Ann Marie Montemurro, Ann Marie Schofield, Antonina Aydanian, Arduino Frankovic, Arlene M Badillo, Azza Talaat, Barbara M Frazier, Barbara T Carmichael, Benjamin J Dastoli, Binh T Nguyen, Bo Chi, PhD, Bonita S Chester, Bradley Dworak, PhD, Brenda W Uratani, PhD, Burnell M Henry, Byungja E Marciante, Calvin B Koerner, Carl Lee, Carlos A Medina, Carolyn Yong, PhD, Caryn M Everly, Caryn M Mcnab, Cassandra Overking, CDR Donald Ertel, CDR Sean T Creighton, CDR Thomas R Berry, PPh, Chad R Burger, Charisse K Green, Charles J Chacko, Charles Jewell, Chava Kimchi Sarfaty, PhD, Cheryl A Grandinetti, Christian D Lynch (CDL), Christina N Maurino, Christina V Santos, Christopher Downey, PhD, Christopher R Czajka, Christopher T Middendorf, Claire M Minden, Claudette D Brooks, Cody D Rickman, Concepcion Cruz, Jr, Cynthia Jim, CSO, Cynthia L Kelley, Daniel C Kearns, Daniel Lagasse, Darcy E Brillhart, David J Hafner, David J Hapner, David S Cho, PhD, Dawn M Braswell, Deborah B Nixon, Deborah M Trout, Debra L Pagano, Decarlos A Gomez, Dell S Moller, Demitria J Argiropoulos, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis E Guilfoyle, PhD, Derek C Price, Devaughn Edwards, Diane L Raccasi, Dmitriy V Volokhov, PhD, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Douglas C Kovacs, Dr. Ralph M Bernstein, PhD, Dr. Willie F Vann, PhD, Dr. Zhihao Qiu (Peter), PhD, Dusty F Snoeberg, Eileen A Liu, Eliezar Ramos, Elizabeth B Griffin, Elizabeth Ll Edwards, Ellen Huang, Elmina E Akwo, Emmanuel Jramos Maldonado, Eric Rothschild, Erika V Butler, Erin D Mccaffery, Ernest H Blackwood, Felix Maldonado, Frederick M Lochner, Freyja V Lynn, Gene D Arcy, George Pyramides, Gerald N Mcgirl, DDS, Gilbert T Salud, Guerlain Ulysse, Hai Lient Phung, Hector A Carrero, Helen B Ricalde, Holly Brevig, Hyesuk Kong, Ibad U Khan, Ivan E Reyes, J David Doleski, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James C Lee, PharmD, James C Maclaughlin, James L Kenney, DSc, James M Simpson, James P Stumpff, James R Evans, James T Mccoy, Janet L Bowen, Jason A Rossi, Jason F Chancey, Jean M Kelahan, Jeffrey M Watson, Jennifer L Bridgewater, Jennifer L Gustavus, Jie He, Joan A Loreng, John D Finkbohner, PhD, John D White, John F Cipollo, John M Mcinnis, John M Mclnnis, John S Hartford, John Stansberry, PhD, Jonee J Mearns, Jorge L Lajara, Jose Acruz Gonzalez, Joseph F Owens, Joseph George, Joseph Kutze, PhD, Joyce A Rockwell, Jude C Dikes, Julie D Bringger, Justin A Boyd, Kaarin M Slotte, Kalavati Suvarna, PhD, Karen A Coleman, Karen E D'orazio, Karen L Kosar, Karen M Kondas, Kassa Ayalew, MD, Katherine E Jacobitz, Kathleen D Culver, Kathleen R Jones, PhD, Kenneth Nieves, Kevin A Gonzalez, Kevin P Foley, Kham Phommachanh, Kimberly M Bigler, Kirsten L Vadheim, PhD, Kristina L Conroy, Kula N Jha, Kurt A Brorson, PhD, Lata C Mathew, PhD, Laura E Garcia, Laura I Salazar, PhD, Laureen M Geniusz, Laurel A Beer, Laurie B Frazier, Laurie P Norwood, LCDR Debra Emerson, Lei Zhang, PhD, Leslie D Wagner, Lewis K Antwi, Liatte Kreuger, PharmD, Linda R Kuchenthal, Linda Thai, Lisa Harlan, Lisa M Parsons, Lois K Gross, Lori Peters, Lori S Lawless, Lourdes Andujar, Luis Soto Lopez, Malgorzata G Norton, PhD, Marc S Neubauer, Margaret E Walsh, Margaret Norton, Maria A Ruttell, Maria Joselopez Barragan, PhD, Marie A Fadden, Marion Michaelis, Mariza M Jafary, Marjorie A Shapiro, PhD, Mark A Elengold, Mark Brunswick, PhD, Mark E Parmon, Mark R Mcclain, Marla A Cassidy, Marsha W Major, Martha T Olone, Mary Davis Lopez, Mary E Storch, Mary T Carden, Mate Tolnay, Matthew A Spataro, Matthew D Silverman, Mayar M Mussa, Meihong Liu, Melanie W Pishnery, Melissa T Roy, Miaja Umaedi, Michael A Taylor, Michael C Kennedy, PhD, Michael E Clark, Michael P Sheehan, Michael Serrano, Michael Shanks, MS, Michele L Forster, PhD, Michelle D Haamid, Michelle Yclark Stuart, Mihaly S Ligmond, Milan S Blake, Milos Dokmanovic, PhD, Monica Commerford, PhD, Morris Sheldon, PhD, Mra Munizn, Myriam M Sosa, Nabil Nakhoul, Nancy E Kirschbaum, Nancy L Neiger, Nancy T Waites, Natalya M Ananyeva, Nicholas A Violand, Nicholas L Paulin, Nicholas Obiri, PhD, Nicole K Trudel, Nina Yang, Nobuko H Katagiri, Noreen Muñiz, Norman K Starks, Olga Simakova, PhD, Omotunde O Osunsanmi, Pablo Feliciano, Pankaj H Amin, Patricia A Morrow, Patricia F Hudson, Paul A Bonneau, Paul L Bellamy, Paul Mouris, Paul W Moy, Paula A Trost, Peng Zhou, Perry T Nichols, Peter R Lenahan, Prabhu P Raju, Priscilla M Pastrana, Qing Joanna Zhou, PhD, Ralph A Erickson, Ramjay Vatsan, PhD, Raymond W Brullo, Rebecca K Olin, Rebecca Rodriguez, Regina Gibson Melton, Regina T Brown, Reyes Candau Chacon, PhD, Richard H Penta, Richard Heath Coats, Richard Ledwidge (nmi), PhD, Richard W Berning, Richard W Thornton, Robert C Coleman, Robert D Tollefsen, Robert J Martin, Robin Levis, PhD, Rodney T Allnutt, Roman T Drews, PhD, Rona A Leblanc, PhD, Ronald T Nowalk, Rose Ashley, Saeid E Kazan, Samuel L Murray, Sarah B Tanksley, Sayeeda Hdabe, Scott E Norris, Scott T Ballard, Seneca D Toms, Shafiq S Ahadi, Shankar L Saha, Sheldon Morris, Shelley L Waring, Sheri L Stephenson, Sidney B Priesmeyer, Simone E Pitts, Sneha S Patel, Stephanie A Slater, MS, Stephanie T Durso, Stephen D Brown, Stephen J Kilker, Steven A Rubin, Steven E Bowen, PhD, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susan M Turcovski, Susan Yu, Svetlana A Shestopal, Tamala P Bogan, Tamala P Magee, Tamara M Casselman, Tamara M Kays, Tammy L Chavis, Terri L Dodds, Terrig Thomas, PhD, Thai D Truong, Thomas E Friel, Thomas J Arista, Thuy T Nguyen, LCDR, Tina S Roecklein, Tonia F Bernard, Trang N Cox, Troy C Quander, Tyanna N Hadley, Unnee Ranjan, Veronica Fuentes, MS, Vijaya L Simhadri, Vilmary Negron Rodriguez, Virgilio F Pacio, CSO, Viviana Matta, Walter N Lange, Wayne E Seifert, Wei Wang, PhD, Yanming An, PhD, Yonggang Wang, PhD, Yvesna C Blaise, Yvins Dezan, Zerita White, Zhao Wang, PhD, Zhong Li, PhD, Ziyang Su, PhD, Zuben E Sauna, PhD

Robert Jennings's Documents

Publish Date Document Type Title
May, 2002 FDA 483 BioReliance Corporation - Form 483, 2002-05-01
June, 2001 EIR BAXALTA US INC. - EIR, 2001-06-21
June, 2003 FDA 483 Seqirus Vaccines Limited - Form 483, 2003-06-10
June, 2002 EIR Boehringer Ingelheim Pharma GmbH and Co. KG - EIR, 2002-06-20
August, 2000 FDA 483 Murex Diagnostics Inc - Form 483, 2000-08-24
November, 2000 FDA 483 Grifols Therapeutics LLC - Form 483, 2000-11-17
May, 2002 EIR BioReliance Corporation - EIR, 2002-05-01
March, 2001 EIR Grifols Therapeutics LLC - EIR, 2001-03-21
September, 2002 EIR GSK Vaccines GmbH - EIR, 2002-09-20
November, 2002 FDA 483 Response Lonza Walkersville, Inc. - Form 483R, 2002-11-20
September, 2002 FDA 483 GSK Vaccines GmbH - Form 483, 2002-09-20
November, 2000 FDA 483 Response Grifols Therapeutics LLC - Form 483R, 2001-01-12
November, 2002 EIR Lonza Walkersville, Inc. - EIR, 2002-11-14
June, 2003 FDA 483 Response Seqirus Vaccines Limited - Form 483R, 2003-06-27
January, 2002 FDA 483 Vespa Laboratories, Inc. - Form 483, 2002-01-10
November, 2000 EIR Grifols Therapeutics LLC - EIR, 2000-11-17
August, 2000 FDA 483 Response Murex Diagnostics Inc - Form 483R, 2000-09-09
January, 2002 FDA 483 Biogen MA Inc. - Form 483, 2002-01-31
August, 2000 EIR Murex Diagnostics Inc - EIR, 2000-08-24
June, 2001 FDA 483 BAXALTA US INC. - Form 483, 2001-06-21
May, 2002 FDA 483 ADMA Biologics, Inc - Form 483, 2002-05-22
August, 2002 FDA 483 Merck Teknika LLC - Form 483, 2002-08-12
June, 2002 FDA 483 Alk-abello A/s - Form 483, 2002-06-07
January, 2002 EIR Biogen MA Inc. - EIR, 2002-01-31
June, 2002 FDA 483 Response Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483R, 2002-06-28
March, 2002 FDA 483 Bayer HealthCare LLC - Form 483, 2002-03-15
November, 2002 FDA 483 Lonza Walkersville, Inc. - Form 483, 2002-11-14
October, 2003 FDA 483 Response Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483R, 2003-12-17
May, 2001 FDA 483 Grifols Biologicals LLC - Form 483, 2001-05-07
July, 2000 EIR Organon Teknika B.V. - bioMerieux, BV - EIR, 2000-07-10
May, 2001 EIR Grifols Biologicals LLC - EIR, 2001-05-07
October, 2003 EIR Pfizer, Inc. - EIR, 2003-10-17
March, 2002 EIR Bayer HealthCare LLC - EIR, 2002-03-15
June, 2002 FDA 483 Boehringer Ingleheim Pharma KG - Form 483, 2002-06-20
September, 2001 FDA 483 Research Foundation for Microbial Diseases (Biken) - Form 483, 2001-09-19
March, 2001 FDA 483 Grifols Therapeutics LLC - Form 483, 2001-03-21
June, 2000 FDA 483 Organon Teknika b.v. - Form 483, 2000-07-10
November, 2001 FDA 483 Associates of Cape Cod, Inc. - Form 483, 2001-11-09
November, 2001 EIR Associates of Cape Cod, Inc. - EIR, 2001-11-09
October, 2001 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2001-10-26
October, 2001 EIR Ben Venue Laboratories Inc. - EIR, 2001-10-26
January, 2004 FDA 483 Ortho Biologics LLC - Form 483, 2004-01-20
October, 2003 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2003-10-28
October, 2003 FDA 483 Pfizer, Inc. - Form 483, 2003-10-17
March, 2001 FDA 483 Response Grifols Therapeutics LLC - Form 483R, 2001-06-08
January, 2004 EIR Ortho Biologics LLC - EIR, 2004-01-20
October, 2003 EIR Wyeth Pharmaceutical Division of Wyeth Holdings LLC - EIR, 2003-10-28
June, 2003 EIR Seqirus Vaccines Limited - EIR, 2003-06-10
May, 2002 FDA 483 Response BioReliance Corporation - Form 483R, 2002-05-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more